[go: up one dir, main page]

WO2007078176A1 - The method of making optically active 2-chloromandelic acid esters and 2-chloromandelic acids by enzymatic method - Google Patents

The method of making optically active 2-chloromandelic acid esters and 2-chloromandelic acids by enzymatic method Download PDF

Info

Publication number
WO2007078176A1
WO2007078176A1 PCT/KR2007/000085 KR2007000085W WO2007078176A1 WO 2007078176 A1 WO2007078176 A1 WO 2007078176A1 KR 2007000085 W KR2007000085 W KR 2007000085W WO 2007078176 A1 WO2007078176 A1 WO 2007078176A1
Authority
WO
WIPO (PCT)
Prior art keywords
optically active
chloromandelic
chloromandelic acid
acid esters
acids
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Ceased
Application number
PCT/KR2007/000085
Other languages
French (fr)
Inventor
Soon Ook Hwang
Sun Ho Chung
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Enzytech Ltd
Original Assignee
Enzytech Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Enzytech Ltd filed Critical Enzytech Ltd
Publication of WO2007078176A1 publication Critical patent/WO2007078176A1/en
Anticipated expiration legal-status Critical
Ceased legal-status Critical Current

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12PFERMENTATION OR ENZYME-USING PROCESSES TO SYNTHESISE A DESIRED CHEMICAL COMPOUND OR COMPOSITION OR TO SEPARATE OPTICAL ISOMERS FROM A RACEMIC MIXTURE
    • C12P41/00Processes using enzymes or microorganisms to separate optical isomers from a racemic mixture
    • C12P41/003Processes using enzymes or microorganisms to separate optical isomers from a racemic mixture by ester formation, lactone formation or the inverse reactions
    • C12P41/005Processes using enzymes or microorganisms to separate optical isomers from a racemic mixture by ester formation, lactone formation or the inverse reactions by esterification of carboxylic acid groups in the enantiomers or the inverse reaction
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12PFERMENTATION OR ENZYME-USING PROCESSES TO SYNTHESISE A DESIRED CHEMICAL COMPOUND OR COMPOSITION OR TO SEPARATE OPTICAL ISOMERS FROM A RACEMIC MIXTURE
    • C12P7/00Preparation of oxygen-containing organic compounds
    • C12P7/02Preparation of oxygen-containing organic compounds containing a hydroxy group
    • C12P7/22Preparation of oxygen-containing organic compounds containing a hydroxy group aromatic
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12PFERMENTATION OR ENZYME-USING PROCESSES TO SYNTHESISE A DESIRED CHEMICAL COMPOUND OR COMPOSITION OR TO SEPARATE OPTICAL ISOMERS FROM A RACEMIC MIXTURE
    • C12P7/00Preparation of oxygen-containing organic compounds
    • C12P7/62Carboxylic acid esters
    • YGENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10TECHNICAL SUBJECTS COVERED BY FORMER USPC
    • Y10STECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10S435/00Chemistry: molecular biology and microbiology
    • Y10S435/8215Microorganisms
    • Y10S435/822Microorganisms using bacteria or actinomycetales
    • Y10S435/832Bacillus
    • Y10S435/839Bacillus subtilis
    • YGENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10TECHNICAL SUBJECTS COVERED BY FORMER USPC
    • Y10STECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10S435/00Chemistry: molecular biology and microbiology
    • Y10S435/8215Microorganisms
    • Y10S435/911Microorganisms using fungi
    • Y10S435/913Aspergillus
    • Y10S435/918Aspergillus oryzae
    • YGENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10TECHNICAL SUBJECTS COVERED BY FORMER USPC
    • Y10STECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10S435/00Chemistry: molecular biology and microbiology
    • Y10S435/8215Microorganisms
    • Y10S435/911Microorganisms using fungi
    • Y10S435/921Candida

Definitions

  • the present invention relates to process for the preparation of optically active
  • optically active 2-chloromandelic acid ester represented by the general formula 2 and optically active 2-chloromandelic acid represented by the general formula 3 are prepared from racemic 2-chloromandelic acid ester represented by the general formula 1 in scheme 1 by hydrolases or hydrolase-producing microorganisms.
  • R is selected from substituted or unsubstituted alkyl groups or alkenyl groups wherein the alkyl contains from C i to C , benzyl groups, cycloalkyl groups comprising from C 3 to C 6 , substituted or unsubstituted arylalkyl groups, and substituted or unsubstituted heteroarylalkyl groups.
  • Optically active 2-chloromandelic acid esters are valuable chiral intermediates for synthesizing (S)-clopidogrel bisulfate with platelet aggregation inhibiting activity.
  • Tosylated or mesylated compounds can be converted to optically active 2-chlorostyrene oxide which is used for important pharmaceutical intermediates by epoxydation (Korea Patent 10-2005-0035057).
  • Noda Hirobumi et al.(JP-0072644) prepared a diastereomer salt by reacting racemic 2-chloromandelic acid with an optically active N-benzyl-1-phenylethylamine as an optical resolution agent and obtained (R)-2-chloromandelic acid by acidification of a diastereomer salt.
  • this method needs recrystallization process.
  • Hyoda Toshiharu et al.(JP-0114737) obtained (R)-2-choloromandelic acid using optically active alanine as an optical resolution agent.
  • the present invention provides the new method of preparing of optically active 2-chloromandelic acid esters and their acids by hydrolases or hydrolase-producing microorganisms. And this method can be used in practical process because seperation and recovery of 2-chloromandelic acid esters and their acids produced by this invention are easier.
  • this invention includes the process for preparing optically active 2-chloromandelic acid ester and optically active 2-chloromandelic acid by stereospecific hydrolysis of racemic 2-chloromandelic acid ester using hydrolases or hydrolase-producing mi- croorganisms. And optically active 2-chloromandelic acid ester is converted to optically active 2-chloromandelic acid by hydrolysis using agents such as sodium hydroxide.
  • hydrolases such as CAL A(Novozym
  • CAL B(Novozym 435), alcalase, and protease A or hydrolase-producing microorganisms are used as biocatalysts.
  • Racemic 2-chloromandelic acid ester was determined using gas chromatography (Donam Instrument Inc., Model 6200) equipped with HP-FFAP column(Agilent, Inc., 3O m X 0.53 mm). The oven temperature was maintained initially at 100 0 C for 5 min and then raised at the rate of 20 °C/min to 220 0 C, and maintained for 10 min. Helium gas was used as carrier and column head pressure was maintained at 6 psi, and compounds were detected using FID at 220 0 C. In this condition, the typical retention time of methyl 2-chloromandelate, ethyl 2-chloromandelate and butyl 2-chloromandelic acid was 15.31 min, 14.89 min and 17.28 min, respectively.
  • racemic 2-chloromandelic acid was added to 40ml of methanol and 35 % HCl solution. The reaction was carried out at 75 0 C for 3 hours. The reaction mixture was neutralized and racemic methyl 2-chloromandelate was gained by solvent extraction and distillation under reduced pressure. Racemic ethyl 2-chloromandelate and butyl 2-chloromandelate were synthesized using ethanol or buthanol, respectively instead of methanol. And the products were confirmed by nuclear magnetic resonance(Burker, Model DRS300).
  • Example 2-3 Preparing of optically active methyl 2-chloromandelate by hydrolysis
  • Racemic methyl 2-chloromandelate(l %(v/v)) prepared in Example 1 was added to 5 ml of 0.1 M potassium phosphate buffer(pH 7.0) and the reaction was carried out at 30 0 C using enzymes (1 %(w/v)). The reaction mixture was extracted with ethyl acetate and analyzed by above-mentioned method. The results are shown in Table 1.
  • Example 4-7 Preparing of optically active ethyl 2-chloromandelate by hydrolysis [46] [47] Instead of racemic methyl 2-chloromandelate used in Example 2, ethyl 2-chloromandelate was used as a reactant and the results are shown in Table 2.
  • Example 8 Preparing of optically active butyl 2-chloromandelate by hydrolysis [51] [52] Instead of racemic methyl 2-chloromandelate used in Example 2, butyl 2-chloromandelate was used as a reactant and CAL B was used as a biocatalyst. The reaction was carried out for 48 hours and butyl (R)-2-chloromandelate was obtained with 76 e.e% (conversion 93.1%).
  • optically active 2-chloromandelic acid ester can be produced easily by this invention, and the product with high optical purity was obtained. Also, it is easy to recover optically active esters and optically active 2-chlromandelic acids after reaction. Therefore, this method is an useful process on the industrial scale.

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Zoology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Wood Science & Technology (AREA)
  • Biotechnology (AREA)
  • Microbiology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Health & Medical Sciences (AREA)
  • Biochemistry (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • General Engineering & Computer Science (AREA)
  • General Health & Medical Sciences (AREA)
  • Genetics & Genomics (AREA)
  • Analytical Chemistry (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)

Abstract

The present invention relates to process for the preparation of optically active 2-chloromandelic acid esters represented by the general formula 2 and optically active 2-chloromandelic acids represented by the general formula 2 which are used intensively as important chiral intermediates. In more detail, this invention relates to the process for preparing optically active 2-chloromandelic acid esters and optically active 2-chloromandelic acids by stereospecific hydrolysis of racemic 2-chloromandelic acid ester using lipases or lipase-producing microorganisms in the aqeous phase or organic phase including aqeous solvent. The method of making optically active 2-chloromandelic aicd esters and their acids is usful in the practical process because production of seperation of compounds with high optical purity are easy.

Description

Description THE METHOD OF MAKING OPTICALLY ACTIVE
2-CHLOROMANDELIC ACID ESTERS AND 2-CHLOROMANDELIC ACIDS BY ENZYMATIC METHOD
Technical Field
[1] The present invention relates to process for the preparation of optically active
2-chloromandelic acid esters and their acids by enzymes or microorganisms. In more detail, optically active 2-chloromandelic acid ester represented by the general formula 2 and optically active 2-chloromandelic acid represented by the general formula 3 are prepared from racemic 2-chloromandelic acid ester represented by the general formula 1 in scheme 1 by hydrolases or hydrolase-producing microorganisms.
[2] [ Scheme 1]
[3]
Figure imgf000002_0001
[4] In scheme 1, R is selected from substituted or unsubstituted alkyl groups or alkenyl groups wherein the alkyl contains from C i to C , benzyl groups, cycloalkyl groups comprising from C 3 to C 6 , substituted or unsubstituted arylalkyl groups, and substituted or unsubstituted heteroarylalkyl groups.
[5] Optically active 2-chloromandelic acid esters are valuable chiral intermediates for synthesizing (S)-clopidogrel bisulfate with platelet aggregation inhibiting activity. Tosylated or mesylated compounds can be converted to optically active 2-chlorostyrene oxide which is used for important pharmaceutical intermediates by epoxydation (Korea Patent 10-2005-0035057).
[6]
Background Art
[7] Noda Hirobumi et al.(JP-0072644) prepared a diastereomer salt by reacting racemic 2-chloromandelic acid with an optically active N-benzyl-1-phenylethylamine as an optical resolution agent and obtained (R)-2-chloromandelic acid by acidification of a diastereomer salt. However, this method needs recrystallization process. Likewise, Hyoda Toshiharu et al.(JP-0114737) obtained (R)-2-choloromandelic acid using optically active alanine as an optical resolution agent. [8] North Michael et al.(W0 02/10095 A3) prepared (R)-O-acetyl-cyanohydrin by cyanation and acetylation from 2-chlorobenzaldehyde using chiral ligand and chiral catalyst and obtained(R)-2-chloromandelic acid by hydrolysis of (R)-O-acety 1- cyanohydrin. This process needs recrystallization step and has some problem during the reaction.
[9] On the other hand, there are several methods to prepare optically active
2-chloromandelic acid using enzyme and microorganisms.
[10] Kim et al.(KP 10-2004-0063264) prepared (R)-2-chloromandelic acid and their ester using Baker's yeast. 2-chloromandelic acid alkyl ester was produced from 2-chloromandelic acid and converted to alkyl 2-chloro-benzoylformate, By asymmetic reduction using Baker's yeast, methyl 2-chloro-benzoylformate, ethyl 2-chloro-benzoylformate and butyl 2-chloro-benzoylformate were converted to 2-chloromandelic acid alkyl esters. Their converion was 99.9 %, 88.5%, 99.7 % and optical purity was 98.45, 98.5, 98.4 e.e%, respectively. This process has a disadvartage because of many reaction steps.
[11] Korea Patent( 10-2005-0035057) presents the method of preparing
(R)-2-chloromandelic acid ester(100 e.e%) and (S)-2-chloromandelic acid diester by esterifiction of racemic 2-chloromandelic acid ester using lipase in organic phase. However, this method has some problem in seperation and recovery after reaction.
[12] Van Langen et al. (Organic Process Research & Development, 2003, 7, 828-831) synthesized 2-(2-chlorophenyl)-2-hydroxyacetonitrile from 2-chlorobenzaldehyde using oxynitrilase and obtained (R)-2-choloromandelic acid (99 e.e%) by hydrolysis and recrystallization.
[13]
Disclosure of Invention Technical Problem
[14] With this in mind, We, inventors developed the method which is simple and easy in product recovery comparing to the conventional methods. The present invention provides the new method of preparing of optically active 2-chloromandelic acid esters and their acids by hydrolases or hydrolase-producing microorganisms. And this method can be used in practical process because seperation and recovery of 2-chloromandelic acid esters and their acids produced by this invention are easier. Technical Solution
[15] The invention is explained in more detail as follows. As previously stated, this invention includes the process for preparing optically active 2-chloromandelic acid ester and optically active 2-chloromandelic acid by stereospecific hydrolysis of racemic 2-chloromandelic acid ester using hydrolases or hydrolase-producing mi- croorganisms. And optically active 2-chloromandelic acid ester is converted to optically active 2-chloromandelic acid by hydrolysis using agents such as sodium hydroxide.
[16] In preparing optically active compounds, hydrolases such as CAL A(Novozym
735), CAL B(Novozym 435), alcalase, and protease A or hydrolase-producing microorganisms are used as biocatalysts.
[17] In this invention, reactants and products were analyzed as belows.
[18] Racemic 2-chloromandelic acid ester was determined using gas chromatography (Donam Instrument Inc., Model 6200) equipped with HP-FFAP column(Agilent, Inc., 3O m X 0.53 mm). The oven temperature was maintained initially at 100 0C for 5 min and then raised at the rate of 20 °C/min to 220 0C, and maintained for 10 min. Helium gas was used as carrier and column head pressure was maintained at 6 psi, and compounds were detected using FID at 220 0C. In this condition, the typical retention time of methyl 2-chloromandelate, ethyl 2-chloromandelate and butyl 2-chloromandelic acid was 15.31 min, 14.89 min and 17.28 min, respectively.
[19] Optically active 2-chloromandelic acid ester was determined by HPLC(Lab
Aliance, Model 201) equipped with chiral column AD-H(Daicel). Hexane and isopropyl alcohol mixture(90:10) used as mobile phase and flow rate was 0.7 ml/min, and the absorbance was 220 nm. The typical retention time of the compound in this condition was as follows:
[20] methyl (S)-2-chloromandelate - 12.71 min
[21] methyl (R)-2-chloromandelate - 13.93 min
[22] ethyl (S)-2-chloromandelate - 12.00 min
[23] ethyl (R)-2-chloromandelate - 13.95 min
[24] butyl (S)-2-chloromandelate - 10.36 min
[25] butyl (R)-2-chloromandelate - 12.06 min
[26]
[27] The following specific examples are intended to be illustrative of the invention and should not be construed as limiting the scope of the invention as defined by appended claims.
[28]
[29] Example 1. Preparing of racemic alkyl 2-chloromandelate
[30]
[31] 2g of racemic 2-chloromandelic acid was added to 40ml of methanol and 35 % HCl solution. The reaction was carried out at 75 0C for 3 hours. The reaction mixture was neutralized and racemic methyl 2-chloromandelate was gained by solvent extraction and distillation under reduced pressure. Racemic ethyl 2-chloromandelate and butyl 2-chloromandelate were synthesized using ethanol or buthanol, respectively instead of methanol. And the products were confirmed by nuclear magnetic resonance(Burker, Model DRS300).
[32] Methyl 2-chloromandelate [33] 1H-NMR(CDCl , 300MHz) δ(ppm) = 3.76(s, 3H), 5.57(s, IH), 7.27(m, 2H), 7.39(m, 2H)
[34] Ethyl 2-chloromandelate [35] 1H-NMR(CDCl , 300MHz) δ(ppm) = 1.21(t, 3H), 4.21(m, 2H), 5.54(s, IH), 7.27(m, 2H), 7.38(m, 2H)
[36] Butyl 2-chloromandelate [37] 1H-NMR(CDCl , 300MHz) δ(ppm) = 0.83(t, 3H), 1.23(m, 2H), 1.54(m, 2H), 4.16(t, 2H), 5.56(s, IH), 7.25(m, 2H), 7.38(m, 2H)
[38] [39] [40] Example 2-3. Preparing of optically active methyl 2-chloromandelate by hydrolysis [41] [42] Racemic methyl 2-chloromandelate(l %(v/v)) prepared in Example 1 was added to 5 ml of 0.1 M potassium phosphate buffer(pH 7.0) and the reaction was carried out at 30 0C using enzymes (1 %(w/v)). The reaction mixture was extracted with ethyl acetate and analyzed by above-mentioned method. The results are shown in Table 1.
[43] Table 1
Figure imgf000005_0001
[44] [45] Example 4-7. Preparing of optically active ethyl 2-chloromandelate by hydrolysis [46] [47] Instead of racemic methyl 2-chloromandelate used in Example 2, ethyl 2-chloromandelate was used as a reactant and the results are shown in Table 2.
[48] Table 2
Figure imgf000005_0002
Figure imgf000006_0001
[49] [50] Example 8. Preparing of optically active butyl 2-chloromandelate by hydrolysis [51] [52] Instead of racemic methyl 2-chloromandelate used in Example 2, butyl 2-chloromandelate was used as a reactant and CAL B was used as a biocatalyst. The reaction was carried out for 48 hours and butyl (R)-2-chloromandelate was obtained with 76 e.e% (conversion 93.1%).
[53] [54] Example 9. Preparing of optically active (R)-chloromandelic acid [55] [56] Ethyl (2)-2-chloromandelate (99 ee%) was prepared from racemic ethyl 2-chloromandelate by hydrolysis using CAL B. Ethyl (R)-2-chloromandelate was dissolved in methanol and 10 %(w/v) sodium hydroxide solution was added to this reaction mixture. After reaction at room temperature, reaction mixture was acidified to pH 1 and white solid was obtained by solvent extraction using t-butyl methyl ester(t-BME). (R)-2-chloromandelic acid (99e.e%) was obtained.
[57]
Industrial Applicability [58] In accordance with Examples 2-9, optically active 2-chloromandelic acid ester can be produced easily by this invention, and the product with high optical purity was obtained. Also, it is easy to recover optically active esters and optically active 2-chlromandelic acids after reaction. Therefore, this method is an useful process on the industrial scale.
[59] [60]

Claims

Claims
[1] A process preparing for optically active 2-chloromandelic acid esters represented by the general formula 2 and optically active 2-chloromandelic acids represented by the general formula 3 by hydrolysis from racemic 2-chloromandelic acid esters represented by the general formula 1 using hydrolases or hydrolase- producing microorganisms as biocatalysts. [Scheme 1]
Figure imgf000007_0001
In scheme 1, R is selected from substituted or unsubstituted alkyl groups or alkenyl groups wherein the alkyl contains from C i to C , benzyl groups, cycloalkyl groups comprising from C to C , substituted or unsubstituted
3 6 arylalkyl groups, and substituted or unsubstituted heteroarylalkyl groups. [2] A process prepaing for optically active 2-chloromandelic acid esters and optically active 2-chloromandelic acids according to claim 1, wherein the biocatalyst are lipase, esterase, protease or these enzyme-producing microorganisms.
PCT/KR2007/000085 2006-01-05 2007-01-05 The method of making optically active 2-chloromandelic acid esters and 2-chloromandelic acids by enzymatic method Ceased WO2007078176A1 (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
KR10-2006-0001422 2006-01-05
KR1020060001422A KR100722155B1 (en) 2006-01-05 2006-01-05 Method for preparing optically active 2-chloromandelic acid ester and 2-chloromandelic acid by enzymatic method

Publications (1)

Publication Number Publication Date
WO2007078176A1 true WO2007078176A1 (en) 2007-07-12

Family

ID=38228460

Family Applications (1)

Application Number Title Priority Date Filing Date
PCT/KR2007/000085 Ceased WO2007078176A1 (en) 2006-01-05 2007-01-05 The method of making optically active 2-chloromandelic acid esters and 2-chloromandelic acids by enzymatic method

Country Status (2)

Country Link
KR (1) KR100722155B1 (en)
WO (1) WO2007078176A1 (en)

Cited By (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN102206686A (en) * 2011-04-19 2011-10-05 华东理工大学 Preparation method of methyl (R)-o-chloromandelate utilizing biocatalytic asymmetric reduction
CN108192932A (en) * 2017-12-26 2018-06-22 上海皓元生物医药科技有限公司 A kind of enzymatic preparation method of chiral alcohol
CN111118073A (en) * 2019-12-27 2020-05-08 东莞市东阳光生物合成药有限公司 Method for synthesizing intermediate of ezetimivir by enzyme method

Citations (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5580765A (en) * 1993-02-03 1996-12-03 Nitto Chemical Industry Co., Ltd. Process for producing optically active a-hydroxycarboxylic acid having phenyl group using gordona terrae
JP2001072644A (en) * 1999-09-06 2001-03-21 Yamakawa Yakuhin Kogyo Kk Method for producing optically active 2-chloromandelic acid and intermediate for production
JP2002114737A (en) * 2000-10-11 2002-04-16 Japan Hydrazine Co Inc METHOD FOR PRODUCING OPTICALLY ACTIVE o-CHLOROMANDELIC ACID
EP1382674A2 (en) * 2002-07-16 2004-01-21 Daicel Chemical Industries, Ltd. Alpha-keto acid reductase, method for producing the same, and method for producing optically active alpha-hydroxy acids using the same

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
KR100651338B1 (en) * 2003-01-06 2006-11-28 에스케이 주식회사 Method for preparing optically active (R) -2-chloromandelic acid and its ester derivatives using yeast
KR100752282B1 (en) * 2003-10-11 2007-08-29 주식회사 이큐스팜 Method for preparing 2-chlorostyrene oxide of (R)-or (S) -form using enzyme

Patent Citations (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5580765A (en) * 1993-02-03 1996-12-03 Nitto Chemical Industry Co., Ltd. Process for producing optically active a-hydroxycarboxylic acid having phenyl group using gordona terrae
JP2001072644A (en) * 1999-09-06 2001-03-21 Yamakawa Yakuhin Kogyo Kk Method for producing optically active 2-chloromandelic acid and intermediate for production
JP2002114737A (en) * 2000-10-11 2002-04-16 Japan Hydrazine Co Inc METHOD FOR PRODUCING OPTICALLY ACTIVE o-CHLOROMANDELIC ACID
EP1382674A2 (en) * 2002-07-16 2004-01-21 Daicel Chemical Industries, Ltd. Alpha-keto acid reductase, method for producing the same, and method for producing optically active alpha-hydroxy acids using the same

Cited By (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN102206686A (en) * 2011-04-19 2011-10-05 华东理工大学 Preparation method of methyl (R)-o-chloromandelate utilizing biocatalytic asymmetric reduction
CN102206686B (en) * 2011-04-19 2013-06-26 华东理工大学 Method for preparing (R)-o-chloromandelic acid methyl ester through biocatalytic asymmetric reduction
CN108192932A (en) * 2017-12-26 2018-06-22 上海皓元生物医药科技有限公司 A kind of enzymatic preparation method of chiral alcohol
CN111118073A (en) * 2019-12-27 2020-05-08 东莞市东阳光生物合成药有限公司 Method for synthesizing intermediate of ezetimivir by enzyme method
CN111118073B (en) * 2019-12-27 2022-02-15 宜昌东阳光生化制药有限公司 Method for synthesizing intermediate of ezetimivir by enzyme method

Also Published As

Publication number Publication date
KR100722155B1 (en) 2007-05-28

Similar Documents

Publication Publication Date Title
JPH0436195A (en) Production of optically active alpha-hydroxyesters
WO2007078176A1 (en) The method of making optically active 2-chloromandelic acid esters and 2-chloromandelic acids by enzymatic method
EP2725012A1 (en) 1-amino-2-vinyl cyclopropane carboxylic acid amide, salt of same, and method for producing same
JP6169812B2 (en) Method for producing L-carnitine from beta-lactone using lipase
JP4843812B2 (en) Method for optical resolution of racemic α-substituted heterocyclic carboxylic acids using enzymes
WO2007126258A1 (en) The method of making optically active 2-halo-2-(n-substituted phenyl)acetic acid esters and 2-halo-2-(n-substituted phenyl)acetic acids by enzymatic method
US20020006644A1 (en) Method for preparing an R- or S-form of alpha-substituted heterocyclic carboxylic acid and a counter enantiomeric form of alpha-substituted heterocyclic carboxylic acid ester thereto using enzyme
JP2002171994A (en) Method for producing optically active tetrahydrofuran-2-carboxylic acid or its antipode ester
JP3704731B2 (en) Process for producing optically active 3-hydroxyhexanoic acids
KR100651338B1 (en) Method for preparing optically active (R) -2-chloromandelic acid and its ester derivatives using yeast
JP5506658B2 (en) Method for producing optically active carboxylic acid using esterase derived from thermophilic archaea
JP3583798B2 (en) Method for producing optically active 2-methylbutanoic acid and derivatives thereof
KR100650798B1 (en) Method for preparing optically active carboxylic acid
EP2069516B1 (en) Specific hydrolysis of the n-unprotected (r) -ester of (3 ) -amin0-3-arylpr0pi0nic acid esters
JPH1175889A (en) Production method and purification method of optically active α-trifluoromethyl lactic acid and its enantiomer ester
KR100545472B1 (en) Method for preparing optically active cis-1-Ramino-2-indanol and esters thereof by enzymatic method
KR100758512B1 (en) Method for preparing optically active 3-hydroxy-3-phenylpropionic acid and optically active 3-acyloxy-3-phenylpropionic acid by enzymatic method
WO2007035066A1 (en) The method of making optically active 3-acyloxy-gamma-butyrolactone and optically active 3-hydroxy-gamma-butyrolactone by enzymatic method
JP2007117034A (en) Method for producing optically active nipecotic acid compound
JPWO2004092113A1 (en) Optically active 2-allylcarboxylic acid derivative and process for producing the same
JP2007202563A (en) Method for producing and purifying optically active α-trifluoromethyl lactic acid and its enantiomer ester
JPH10248592A (en) Production of optically active 2-benzylsuccinic acid and its derivative
HK1135434A (en) Specific hydrolysis of the n-unprotected (r) -ester of (3) -amin0-3-arylpr0pi0nic acid esters
JP2008271827A (en) METHOD FOR PRODUCING OPTICALLY ACTIVE N-ARYL-beta-AMINO ACID COMPOUND
JP2004141094A (en) Process for producing optically active 2,3-epoxy-3-cyclohexylpropionic acid and its esters

Legal Events

Date Code Title Description
121 Ep: the epo has been informed by wipo that ep was designated in this application
NENP Non-entry into the national phase

Ref country code: DE

122 Ep: pct application non-entry in european phase

Ref document number: 07708437

Country of ref document: EP

Kind code of ref document: A1